NorthSea Therapeutics
- Biotech or pharma, therapeutic R&D
NorthSea Therapeutics B.V. is a private, late-stage clinical biotechnology company developing novel strategies to treat orphan metabolic, cholestatic, and fibrotic diseases. Its proprietary structurally engineered fatty acids (SEFAs) are designed to target key disease pathways, offering potential first-in-class treatments. With multiple clinical programs in progress, the company leverages a strong scientific foundation to drive innovation and advance new therapeutic approaches for diseases with serious unmet medical needs. NorthSea's $80M Series C financing was co-led by Ysios Capital and Forbion Growth and supported by venBio, Novo Seeds, Sofinnova, BGV and New Science Ventures. Headquartered in the Netherlands, NorthSea also has a presence in Norway and the U.S.
Address
BostonMassachusetts
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}